All filters
Slidesets
Pharmacology Considerations When Choosing INSTIs - David Back, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Toxicity Considerations When Choosing INSTIs - Ian Frank, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Experience with Dolutegravir in First-Line in Brazil - Ricardo Diaz, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Role of INSTIs in HIV Prevention - Mauro Schechter, MD, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
INSTIs Use in Women at Child-Bearing Age: NTD Risks - Isabella Nóbrega, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
INSTIs Use in Pediatrics - Jorge Pinto, MD, DSc
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Time to Change the Paradigm: Two vs. Three Drugs - Estevão Nunes, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Treatment Options for HIV-TB Co-Infection - Carlos Brites, MD, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Long Acting ARV: Drugs and Delivery Systems - David Back, PhD
Presented at:
Salvador HIV Clinical Forum 2019